SlideShare una empresa de Scribd logo
1 de 27
LECOM-Pharmacy School Immunology 01 Overview of the Immune System Dr. Saber Hussein
Reading & Goal ,[object Object],[object Object],[object Object],[object Object]
Why immunology for pharmacists? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Overview of the Immune System ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Learning Objectives ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Protective role of the immune system ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Innate Immunity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Exterior Innate Defenses
Adaptive (Acquired) Immunity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Antibody: A flexible adaptor ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],L chain H chain Papain V C Ag
Phases of the Immune Response ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Active & Passive Immunization ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Self and Nonself ,[object Object],[object Object],[object Object],[object Object],[object Object]
Humoral and Cell-mediated Immunity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Complement Functions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cells of the Immune System ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cells involved in the immune response Hematopoiesis
Functions of Lymphocytes NK (  )
Major histocompatibility complex (MHC) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Cytokines ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clonal Selection Theory ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clonal Selection Epitopes 2, 103, 821 No specialized  receptor Epitopes 2, 103, 821
Benefits of the Immune System ,[object Object],[object Object],[object Object],[object Object]
Harmful Effects of the Immune System ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Genetic Recombination & Immune Response Diversity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Regulation of the immune system ,[object Object],[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Antigen processing and presentation manu
Antigen processing and presentation manuAntigen processing and presentation manu
Antigen processing and presentation manu
 
Pathogenesis41
Pathogenesis41Pathogenesis41
Pathogenesis41
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological tolerance
 
Fundamentals of immunity
Fundamentals of immunityFundamentals of immunity
Fundamentals of immunity
 
Lecture 13
Lecture 13Lecture 13
Lecture 13
 
Immunodeficiency syndromes part 2
Immunodeficiency syndromes   part 2Immunodeficiency syndromes   part 2
Immunodeficiency syndromes part 2
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
TYPE IV HYPERSENSITIVITY
TYPE IV HYPERSENSITIVITYTYPE IV HYPERSENSITIVITY
TYPE IV HYPERSENSITIVITY
 
Antibody
AntibodyAntibody
Antibody
 
Adaptive Immunity Chapter 17 Tortora
Adaptive Immunity Chapter 17 TortoraAdaptive Immunity Chapter 17 Tortora
Adaptive Immunity Chapter 17 Tortora
 
Tolerance & autoimmunity and organ specific autoimmune diseases
Tolerance & autoimmunity and organ specific autoimmune diseasesTolerance & autoimmunity and organ specific autoimmune diseases
Tolerance & autoimmunity and organ specific autoimmune diseases
 
Immunochemistry
ImmunochemistryImmunochemistry
Immunochemistry
 
Autoimmune disorders
Autoimmune disordersAutoimmune disorders
Autoimmune disorders
 
Chap21 Immune Disorders
Chap21 Immune DisordersChap21 Immune Disorders
Chap21 Immune Disorders
 
Ag ab interaction
Ag ab interactionAg ab interaction
Ag ab interaction
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Lymphocytes
LymphocytesLymphocytes
Lymphocytes
 
Types of Immunity | Dr.BGR Publications
Types of Immunity | Dr.BGR Publications Types of Immunity | Dr.BGR Publications
Types of Immunity | Dr.BGR Publications
 
Autoimmunity and autoimmune disease
Autoimmunity and autoimmune diseaseAutoimmunity and autoimmune disease
Autoimmunity and autoimmune disease
 
Inmunodeficiencias
Inmunodeficiencias Inmunodeficiencias
Inmunodeficiencias
 

Similar a Immuno1 overview

Chap19b Acquired Immune Response
Chap19b Acquired Immune ResponseChap19b Acquired Immune Response
Chap19b Acquired Immune ResponseAnalin Empaynado
 
Bohomolets Microbiology Lecture #10
Bohomolets Microbiology Lecture #10Bohomolets Microbiology Lecture #10
Bohomolets Microbiology Lecture #10Dr. Rubz
 
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventuraShabab Ali
 
immunology presentation
immunology presentationimmunology presentation
immunology presentationMD ROBEL AHMED
 
Immune response by Dr. Rakesh Prasad Sah
Immune response by Dr. Rakesh Prasad SahImmune response by Dr. Rakesh Prasad Sah
Immune response by Dr. Rakesh Prasad SahDr. Rakesh Prasad Sah
 
Immunity-Tcell-Bcell-Cytokines
Immunity-Tcell-Bcell-CytokinesImmunity-Tcell-Bcell-Cytokines
Immunity-Tcell-Bcell-CytokinesChintan Patel
 
Immunochemistry by dr.reena
Immunochemistry by dr.reenaImmunochemistry by dr.reena
Immunochemistry by dr.reenaDr.reena singh
 
everything in Innate adaptive immunity @ujjwal sirohi
everything in Innate adaptive immunity @ujjwal sirohieverything in Innate adaptive immunity @ujjwal sirohi
everything in Innate adaptive immunity @ujjwal sirohiujjwal sirohi
 
Types of Immunity and cells
Types of Immunity and cells Types of Immunity and cells
Types of Immunity and cells Ali Safaa97
 
Sistem imun 5.
Sistem imun 5.Sistem imun 5.
Sistem imun 5.adhaqift
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).pptnedalalazzwy
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).pptnedalalazzwy
 

Similar a Immuno1 overview (20)

Immunity&hypersestivity
Immunity&hypersestivityImmunity&hypersestivity
Immunity&hypersestivity
 
Chap19b Acquired Immune Response
Chap19b Acquired Immune ResponseChap19b Acquired Immune Response
Chap19b Acquired Immune Response
 
Bohomolets Microbiology Lecture #10
Bohomolets Microbiology Lecture #10Bohomolets Microbiology Lecture #10
Bohomolets Microbiology Lecture #10
 
Adaptive immunity
Adaptive immunityAdaptive immunity
Adaptive immunity
 
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
 
immunology presentation
immunology presentationimmunology presentation
immunology presentation
 
Basics of Immunity
Basics of ImmunityBasics of Immunity
Basics of Immunity
 
Immune response by Dr. Rakesh Prasad Sah
Immune response by Dr. Rakesh Prasad SahImmune response by Dr. Rakesh Prasad Sah
Immune response by Dr. Rakesh Prasad Sah
 
Adaptive immunity
Adaptive immunityAdaptive immunity
Adaptive immunity
 
Immunity-Tcell-Bcell-Cytokines
Immunity-Tcell-Bcell-CytokinesImmunity-Tcell-Bcell-Cytokines
Immunity-Tcell-Bcell-Cytokines
 
Immunochemistry by dr.reena
Immunochemistry by dr.reenaImmunochemistry by dr.reena
Immunochemistry by dr.reena
 
everything in Innate adaptive immunity @ujjwal sirohi
everything in Innate adaptive immunity @ujjwal sirohieverything in Innate adaptive immunity @ujjwal sirohi
everything in Innate adaptive immunity @ujjwal sirohi
 
Intro Immune
Intro ImmuneIntro Immune
Intro Immune
 
Jimmy
JimmyJimmy
Jimmy
 
Basic Immunology
Basic ImmunologyBasic Immunology
Basic Immunology
 
Types of Immunity and cells
Types of Immunity and cells Types of Immunity and cells
Types of Immunity and cells
 
Sistem imun 5.
Sistem imun 5.Sistem imun 5.
Sistem imun 5.
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).ppt
 
Antigens last (0).ppt
Antigens last (0).pptAntigens last (0).ppt
Antigens last (0).ppt
 
Dr tarek nasrala immunity
Dr tarek nasrala immunityDr tarek nasrala immunity
Dr tarek nasrala immunity
 

Más de mmoney1

Pharm immuno3 &4 q innate immunity & complement
Pharm immuno3 &4 q innate immunity & complementPharm immuno3 &4 q innate immunity & complement
Pharm immuno3 &4 q innate immunity & complementmmoney1
 
Pharm immuno2 cells of the immune system
Pharm immuno2 cells of the immune systemPharm immuno2 cells of the immune system
Pharm immuno2 cells of the immune systemmmoney1
 
Pharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencyPharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencymmoney1
 
Pharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencyPharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencymmoney1
 
Pharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencyPharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencymmoney1
 
Pharm immuno14&15 cancer & transplantpor
Pharm immuno14&15 cancer & transplantporPharm immuno14&15 cancer & transplantpor
Pharm immuno14&15 cancer & transplantpormmoney1
 
Pharm immuno17-18 hypersensitivity por
Pharm immuno17-18 hypersensitivity porPharm immuno17-18 hypersensitivity por
Pharm immuno17-18 hypersensitivity pormmoney1
 
Pharm immuno9-11 portal
Pharm immuno9-11 portalPharm immuno9-11 portal
Pharm immuno9-11 portalmmoney1
 
Pharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunityPharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunitymmoney1
 
A&p 17 receptors and signaling of the ans
A&p 17 receptors and signaling of the ansA&p 17 receptors and signaling of the ans
A&p 17 receptors and signaling of the ansmmoney1
 
A&p 18 ans integration
A&p 18 ans integrationA&p 18 ans integration
A&p 18 ans integrationmmoney1
 
A&p 19 neural integration
A&p 19 neural integrationA&p 19 neural integration
A&p 19 neural integrationmmoney1
 
A&p 20 general sense
A&p 20 general senseA&p 20 general sense
A&p 20 general sensemmoney1
 
A&p 13 spinal cord
A&p 13 spinal cordA&p 13 spinal cord
A&p 13 spinal cordmmoney1
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_changemmoney1
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_changemmoney1
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_changemmoney1
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_changemmoney1
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_changemmoney1
 
Conflict resolution
Conflict resolutionConflict resolution
Conflict resolutionmmoney1
 

Más de mmoney1 (20)

Pharm immuno3 &4 q innate immunity & complement
Pharm immuno3 &4 q innate immunity & complementPharm immuno3 &4 q innate immunity & complement
Pharm immuno3 &4 q innate immunity & complement
 
Pharm immuno2 cells of the immune system
Pharm immuno2 cells of the immune systemPharm immuno2 cells of the immune system
Pharm immuno2 cells of the immune system
 
Pharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencyPharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiency
 
Pharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencyPharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiency
 
Pharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiencyPharm immuno19 immunodeficiency
Pharm immuno19 immunodeficiency
 
Pharm immuno14&15 cancer & transplantpor
Pharm immuno14&15 cancer & transplantporPharm immuno14&15 cancer & transplantpor
Pharm immuno14&15 cancer & transplantpor
 
Pharm immuno17-18 hypersensitivity por
Pharm immuno17-18 hypersensitivity porPharm immuno17-18 hypersensitivity por
Pharm immuno17-18 hypersensitivity por
 
Pharm immuno9-11 portal
Pharm immuno9-11 portalPharm immuno9-11 portal
Pharm immuno9-11 portal
 
Pharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunityPharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunity
 
A&p 17 receptors and signaling of the ans
A&p 17 receptors and signaling of the ansA&p 17 receptors and signaling of the ans
A&p 17 receptors and signaling of the ans
 
A&p 18 ans integration
A&p 18 ans integrationA&p 18 ans integration
A&p 18 ans integration
 
A&p 19 neural integration
A&p 19 neural integrationA&p 19 neural integration
A&p 19 neural integration
 
A&p 20 general sense
A&p 20 general senseA&p 20 general sense
A&p 20 general sense
 
A&p 13 spinal cord
A&p 13 spinal cordA&p 13 spinal cord
A&p 13 spinal cord
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_change
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_change
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_change
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_change
 
Helping patients with_change
Helping patients with_changeHelping patients with_change
Helping patients with_change
 
Conflict resolution
Conflict resolutionConflict resolution
Conflict resolution
 

Último

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 

Último (20)

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 

Immuno1 overview

Notas del editor

  1. immune - modulating therapies ( drugs which adjust the activity of the immune response to a desired level), interferon beta-1b (Betaferon)
  2. Monocyte A relatively large mononuclear leukocyte (16–22 4m in diameter), that normally constitutes 3–7% of the leukocytes of the circulating blood, and is normally found in lymph nodes, spleen, bone marrow, and loose connective tissue. When treated with the usual dyes, monocytes manifest an abundant pale blue or blue-gray cytoplasm that contains numerous, fine, dustlike, red-blue granules; vacuoles are frequently present; the nucleus is usually indented, or slightly folded, and has a stringy chromatin structure that seems more condensed where the delicate strands are in contact. See Also: monocytoid cell, endothelial leukocyte. Origin [mono- + G. kytos, cell]
  3. This slide shows some features of the structure and functions of the Ab
  4. Apoptosis: Programmed cell death; deletion of individual cells by fragmentation into membrane-bound particles, which are phagocytosed by other cells. Whereas some cells (e.g., cardiac and skeletal muscle fibers, CNS neurons) last a lifetime, others (e.g., epithelial and glandular cells, erythrocytes) have limited life-spans, at the end of which they are genetically programmed to self-destruct, usually to be replaced by others formed by mitosis from surviving cells. Cells in tissue cultures spontaneously undergo apoptosis after about 50 cell divisions . In contrast to cell death caused by injury, infection, or circulatory impairment, apoptosis elicits no inflammatory response in adjacent cells and tissues . Features of apoptosis detectable by histological and histochemical methods include cell shrinkage , due chiefly to dehydration; increased membrane permeability , with a rise in intracellular calcium and a fall in pH ; endonucleolysis (fragmentation of nuclear DNA); and ultimately formation of apoptotic bodies , which are absorbed and removed by macrophages . Besides being due to genetic programming, apoptosis can be induced by injury to cellular DNA, as by irradiation and some cytotoxic agents used to treat cancer. It can be suppressed by naturally occurring factors (e.g., cytokines) and by some drugs (e.g., protease inhibitors). Apoptosis typically does not occur in malignant cells. Such cells therefore escape the destiny of their nonmalignant precursor cells and are said to be immortal. Immortalization can occur in various ways. The bcl-2 gene, present in many cancers, directs the production of an enzyme that blocks apoptosis and immortalizes affected cells. Injury to DNA normally triggers apoptosis by activating the p53 tumor suppressor gene, which is missing or mutated in about one-half of all human cancers. Cells that lack this gene can survive chemotherapy and irradiation intended to destroy cancer cells. Failure of apoptosis to occur is also involved in some degenerative diseases, including lupus erythematosus, and may be responsible for cellular damage caused by certain viruses, including HIV. Origin [G. a falling or dropping off, fr. apo, off, + ptosis, a falling]
  5. Clonal expansion- expansion means become more or grow larger; expand your wealth from $1000 to $1 million. clonal means here a clone is expanded; a clone of B or T cells, namely the clone that recognized the Ag
  6. Not based on beneficial or harmful antigen
  7. These reactions may be triggered by the intrinsic ability of the complement system to recognize microbial components or by Abs bound to the microorganism Ehrlich term for the thermolabile substance, normally present in serum, that is destructive to certain bacteria and other cells sensitized by a specific complement-fixing antibody. Complement is a group of at least 20 distinct serum proteins, the activity of which is affected by a series of interactions resulting in enzymatic cleavages and which can follow one or the other of at least two pathways. In the case of immune hemolysis (classical pathway), the complex comprises nine components (designated C1 through C9) that react in a definite sequence and the activation of which is usually effected by the antigen-antibody complex; only the first seven components are involved in chemotaxis, and only the first four are involved in immune adherence or phagocytosis or are fixed by conglutinins. An alternative pathway (see properdin system) may be activated by factors other than antigen-antibody complexes and involves components other than C1, C4, and C2 in the activation of C3. See Also: component of complement. Origin [L. complementum, that which completes, fr. com-pleo, to fill up] complement pathways heparin complement
  8. Fig 2-1 Cells involved in the immune response
  9. LGL =large granulocyte
  10. Uncommitted cells have no specialized receptor Committed B cells possess a specific receptor that recognizes one and only one EPITOPE of an antigen